Trulieve Cannabis (TRLV) stock: Winston Score and insider trades
Trulieve Cannabis Corp. is a cannabis company that grows, processes, and sells marijuana products for both medical and recreational use. Its products include flower, vapes, edibles, and concentrates, sold directly to customers through its own retail dispensaries. Trulieve is one of the largest cannabis retailers in the United States, with a particularly dominant position in Florida's medical marijuana market. Trulieve makes money by selling cannabis products directly to consumers through company-owned stores, which gives it control over pricing and the customer experience. The company operates primarily in the southeastern United States, with Florida as its core market, though it has expanded into states like Pennsylvania, Arizona, and Georgia. Its biggest risk is federal law — cannabis remains illegal at the federal level in the U.S., which limits banking access, raises taxes under IRS code 280E, and blocks the company from listing on major stock exchanges, all of which pressure profitability and growth.
Winston Score: 19 out of 100, Weak
Weak fundamentals across most pillars.
- Quality: Mixed (8/30)
- Growth: Weak (1/20)
- Cash Flow: Mixed (3/10)
- Stability: Mixed (3/10)
- Valuation: Data not available (0/10)
- Ownership: Ownership data not available (not counted) (0/15)
Key Facts
Price: $10.01
Market Cap: $1.7B
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: New York Stock Exchange
Editorial rules set and reviewed by Felix Prehn, Economist and Editor. Figures are refreshed daily from Financial Modeling Prep and company filings; last refreshed 2026-10-16.


